Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Imaging's role in the treatment of HCM | FDA approves new cryoablation system for AFib | Fasting before TAVR
Thursday, August 10, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

How medical imaging helps cardiologists treat hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy expert Sherif F. Nagueh, MD, examined imaging's role in treating this serious condition. 

READ MORE >
HCM expert Sherif F. Nagueh, MD, FACC, FASE, professor of cardiology, Methodist DeBakey Heart and Vascular Center, explains the key points of HCM imaging. #ASE #HCM
Share on Twitter Share on Facebook Share on Linkedin

How medical imaging helps cardiologists treat hypertrophic cardiomyopathy

Share on Twitter Share on Facebook Share on Linkedin
HCM expert Sherif F. Nagueh, MD, FACC, FASE, professor of cardiology, Methodist DeBakey Heart and Vascular Center, explains the key points of HCM imaging. #ASE #HCM
Hypertrophic cardiomyopathy expert Sherif F. Nagueh, MD, examined imaging's role in treating this serious condition. 
READ MORE >

FDA approves Boston Scientific’s new cryoablation system for AFib

The system includes an expandable cryoablation balloon catheter compatible with multiple balloon sizes. 

READ MORE >
Boston Scientific’s POLARx Cryoablation System to treat atrial fibrillation gained FDA approval in August 2023. It is compatible with two balloon sizes, 31 and 28 mm to fit different sized anatomies.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves Boston Scientific’s new cryoablation system for AFib

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific’s POLARx Cryoablation System to treat atrial fibrillation gained FDA approval in August 2023. It is compatible with two balloon sizes, 31 and 28 mm to fit different sized anatomies.
The system includes an expandable cryoablation balloon catheter compatible with multiple balloon sizes. 
READ MORE >

A surgeon's perspective on treating hypertrophic cardiomyopathy

Nicholas Smedira, MD, a cardiovascular surgeon with Cleveland Clinic, discusses septal myectomy and the need to improve overall HCM care with new standards and evidence-based guidelines.

READ MORE >
Photo of a surgical cardiac septal myectomy to treat hypertrophic cardiomyopathy (HCM). Nicholas Smedira MD discusses septal myectomy in HCM patients and the need for more detailed protocols for HCM care. #HCM #ASE #ASE2023 #myectomy
Share on Twitter Share on Facebook Share on Linkedin

A surgeon's perspective on treating hypertrophic cardiomyopathy

Share on Twitter Share on Facebook Share on Linkedin
Photo of a surgical cardiac septal myectomy to treat hypertrophic cardiomyopathy (HCM). Nicholas Smedira MD discusses septal myectomy in HCM patients and the need for more detailed protocols for HCM care. #HCM #ASE #ASE2023 #myectomy
Nicholas Smedira, MD, a cardiovascular surgeon with Cleveland Clinic, discusses septal myectomy and the need to improve overall HCM care with new standards and evidence-based guidelines.
READ MORE >

Relaxed fasting instructions prior to TAVR, other heart procedures do not affect outcomes

Fasting before major operations has been common in healthcare for nearly 80 years, but that has started to change since the turn of the century. 

READ MORE >
fasting before tavr or ablation
Share on Twitter Share on Facebook Share on Linkedin

Relaxed fasting instructions prior to TAVR, other heart procedures do not affect outcomes

Share on Twitter Share on Facebook Share on Linkedin
fasting before tavr or ablation
Fasting before major operations has been common in healthcare for nearly 80 years, but that has started to change since the turn of the century. 
READ MORE >

Featured Articles

Surgeon sues hospital after being fired for discussing TAVR concerns with media

The vascular surgeon was fired after telling the media about a cardiologist who allegedly performed transcatheter aortic valve replacement without the proper credentials. He is now suing the hospital for wrongful termination and defamation.

READ MORE >
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
Share on Twitter Share on Facebook Share on Linkedin

Surgeon sues hospital after being fired for discussing TAVR concerns with media

Share on Twitter Share on Facebook Share on Linkedin
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
The vascular surgeon was fired after telling the media about a cardiologist who allegedly performed transcatheter aortic valve replacement without the proper credentials. He is now suing the hospital for wrongful termination and defamation.
READ MORE >

Why hypertrophic cardiomyopathy may be widely underdiagnosed

One expert believes the lack of standardization for how diagnostic imaging in conducted and reported has led to a major underdiagnosis of HCM.

READ MORE >
Hari Naidu, MD, explains that inconsistent diagnostic imaging and how it is reported has likely led to a major underdiagnosis of HCM. #ASE #ASE2023 #HCM
Share on Twitter Share on Facebook Share on Linkedin

Why hypertrophic cardiomyopathy may be widely underdiagnosed

Share on Twitter Share on Facebook Share on Linkedin
Hari Naidu, MD, explains that inconsistent diagnostic imaging and how it is reported has likely led to a major underdiagnosis of HCM. #ASE #ASE2023 #HCM
One expert believes the lack of standardization for how diagnostic imaging in conducted and reported has led to a major underdiagnosis of HCM.
READ MORE >

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.

READ MORE >
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.
Share on Twitter Share on Facebook Share on Linkedin

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Share on Twitter Share on Facebook Share on Linkedin
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.
Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.
READ MORE >

In Case You Missed It

GE Healthcare recalls certain SpO2 sensors due to risk of serious errors during defibrillation

There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.

READ MORE >
GE Healthcare recall TruSignal SpO2 sensors
Share on Twitter Share on Facebook Share on Linkedin

GE Healthcare recalls certain SpO2 sensors due to risk of serious errors during defibrillation

Share on Twitter Share on Facebook Share on Linkedin
GE Healthcare recall TruSignal SpO2 sensors
There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.
READ MORE >

Harvard researchers unlock the secret to building 3D-printed heart muscles that can beat

Creating these complex structures with 3D printing alone has never been possible—until now. 

READ MORE >
Harvard 3D printed heart muscles
Share on Twitter Share on Facebook Share on Linkedin

Harvard researchers unlock the secret to building 3D-printed heart muscles that can beat

Share on Twitter Share on Facebook Share on Linkedin
Harvard 3D printed heart muscles
Creating these complex structures with 3D printing alone has never been possible—until now. 
READ MORE >

In Other News

Generic substitute for gadolinium-based contrast agent Gadavist hits the market

The contrast agent, simply called Gadobutrol Injection, has been approved by the U.S. Food and Drug Administration and is now available in the United States.

READ MORE >
gadolinium, GBCAs
Share on Twitter Share on Facebook Share on Linkedin

Generic substitute for gadolinium-based contrast agent Gadavist hits the market

Share on Twitter Share on Facebook Share on Linkedin
gadolinium, GBCAs
The contrast agent, simply called Gadobutrol Injection, has been approved by the U.S. Food and Drug Administration and is now available in the United States.
READ MORE >

Rising patient volumes and staffing challenges: 7 takeaways from a new salary survey of radiologists, techs and administrators

The 2023 Radiology Business Salary and Job Satisfaction Report includes survey responses from all members of the imaging team. 

READ MORE >
radiology survey
Share on Twitter Share on Facebook Share on Linkedin

Rising patient volumes and staffing challenges: 7 takeaways from a new salary survey of radiologists, techs and administrators

Share on Twitter Share on Facebook Share on Linkedin
radiology survey
The 2023 Radiology Business Salary and Job Satisfaction Report includes survey responses from all members of the imaging team. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup